Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ETHAMBUTOL HCL 400 MG TABLET

ETHAMBUTOL HYDROCHLORIDE
$0.4493per EA

Strength

400 mg/1

Manufacturer

Epic Pharma LLC

NDC

42806010201

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ETHAMBUTOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075095

On Market Since

3/18/2015

Pharmacological Classes

Antimycobacterial

Price History

1W

0.0%

1M

+0.4%

3M

-1.7%

6M

-4.5%

1Y

-7.8%

3Y

-37.7%

5Y

-31.6%

All

-14.4%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ISONIAZID 50 MG/5 ML SOLUTION
Generic
46287000901•CMP Pharma, Inc.
$0.3100
per ML
ETHAMBUTOL HCL 100 MG TABLET
Generic
68180028001•Lupin Pharmaceuticals Inc.
$0.3332
per EA
ETHAMBUTOL HCL 100 MG TABLET
Generic
54879000101•STI Pharma LLC
$0.3452
per EA
ETHAMBUTOL HCL 400 MG TABLET
Generic
68084028001•American Health Packaging
$0.4493
per EA
ETHAMBUTOL HCL 400 MG TABLET
Generic
68180028101•Lupin Pharmaceuticals Inc.
$0.4493
per EA
ETHAMBUTOL HCL 400 MG TABLET
Generic
54879000201•STI Pharma LLC
$0.4866
per EA
PYRAZINAMIDE 500 MG TABLET
Generic
00054081221•Hikma Pharmaceuticals USA Inc.
$1.5768
per EA
PYRAZINAMIDE 500 MG TABLET
Generic
00054081222•Hikma Pharmaceuticals USA Inc.
$1.5768
per EA
PYRAZINAMIDE 500 MG TABLET
Generic
00054081225•Hikma Pharmaceuticals USA Inc.
$1.5768
per EA
PYRAZINAMIDE 500 MG TABLET
Generic
00054081229•Hikma Pharmaceuticals USA Inc.
$1.5768
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy